One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistent negative symptoms. Amisulpride v. haloperidol

British Journal of Psychiatry

Volumn 171, Issue DEC., 1997, Pages 564-568

  Speller, J C ^a,e   Barnes, T R E ^b   Curson, D A ^b   Pantelis, C ^c   Alberts, J L ^d  

^a Sexual Medicine   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d SANOFI   (France)

^e Nuffield Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; HALOPERIDOL; PROCYCLIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL BEHAVIOR; TACHYCARDIA; TARDIVE DYSKINESIA; URINE RETENTION; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0030719984     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.171.6.564     Document Type: Article

References (27)

1. Altman, D. G. (1991) Practical Statistics for Medical Research. London: Chapman and Hall.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.
3. Andreasen, N. C. (1989) The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations. British Journal of Psychiatry, 155 (suppl. 7), 49-52.
4. Åsberg, M., Montgomery, S. A., Perris, C., et al (1978) A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica, 57 (suppl. 271), 5-27.
5. Barnes, T. R. E. (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672-676.
6. _ (1994) Issues in the clinical assessment of negative symptoms: Editorial review. Current Opinion in Psychiatry, 7, 35-38.
7. _ & Trauer, T. (1982) Reliability and validity of a tardive dyskinesia videotape rating technique. British Journal of Psychiatry, 140, 508-515.
8. _ & McPhillips, M. A. (1996) Antipsychotic-induced extrapyramidal symptoms: Role of anticholinergic drugs in treatment. CNS Drugs, 6, 315-330.
9. Boyer, P., Lecrubier, Y., Puech, A. J., et al (1995) Treatment of negative symptoms in schizophrenia with amisulpride. British Journal of Psychiatry, 166, 68-72.
10. Carpenter, W. T., Conley, R. R., Buchanan, R. W., et al (1995) Patient response and resource management: another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827-832.
11. Delcker, A., Schoon, M. L., Oczkowski, B., et al (1990) Amisulpride versus haloperidol in the treatment of schizophrenic patients - results of a double-blind study. Pharmacopsychiatry, 23, 125-130.
12. Hillert, A., Phillipp, M., Gattaz, W. E., et al (1994) Amisulpride vs. flupenthixol in the treatment of schizophrenia with predominant positive symptomatology: A controlled double-blind study. Neuropsychopharmacology, 10, 31S.
13. Kane, J. M., Rifkin, A., Woerner, M., et al (1983) Low-dose neuroleptic treatment of outpatient schizophrenics. Archives of General Psychiatry, 40, 893-896.
14. _, Honigfeld, G., Singer, J., et al (1988) Clozapine for the treatment-resistant schizophrenic - a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
15. Krawiecka, M., Goldberg, D. & Vaughan, M. A. (1977) A Standardised psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299-308.
16. Loo, H., Poirier-Littre, M.-F., Theron, M., et al (1997) Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia. British Journal of Psychiatry, 170, 18-22.
17. McPhillips, M. A. & Barnes, T. R. E. (1997) Negative symptoms. Current Opinion in Psychiatry, 10, 30-35.
18. Marder, S. R., Van Putten, T., Mintz, J., et al (1984) Costs and benefits of two doses of fluphenazine. Archives of General Psychiatry 41, 1025-1029.
19. _, _, _, et al (1987) Low and conventional dose maintenance therapy with fluphenazine decanoate. Two-year outcome. Archives of General Psychiatry, 44, 518-521.
20. Möller, H.-J., Van Praag, H., Aufdernbrinke, B., et al (1994) Negative symptoms in schizophrenia: considerations for clinical trials: Working group on negative symptoms in schizophrenia. Psychopharmacology, 115, 221-228.
21. Overall, J. E. & Gorham, D. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
22. Paillere-Martinot, M.-L., Lecrubier, Y., Martinot, J.-L., et al (1995) Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. American Journal of Psychiatry, 152, 130-133.
23. Puech, A. J., Lecrubier, Y. & Simon, P. (1984) Pharmacological classification of benzamides. Acta Psychiatrica Scandinavica, (suppl. 311), 139-145.
24. Rey, M. J., Schulz, P., Costa, C., et al (1989) Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. International Clinical Psychopharmacology, 4, 95-104.
25. Schooler, N. R. (1991) Maintenance medication for schizophrenia: strategies for dose reduction. Schizophrenia Bulletin, 17, 311-324.
26. Simpson, G. M. & Angus, J. W. S. (1970) A rating for extrapyramidal side-effects in drug-induced extrapyramidal disorders. Acta Psychiatrica Scandinavica, 212, 11-19.
27. Wykes, T. & Sturt, E. (1984) The assessment of social behaviour in psychiatric patients: an assessment of the reliability and validity of the SBS schedule. British Journal of Psychiatry, 148, 1-11.